Synergistic/additive inhibition of cell proliferation and induction of thyroid iodide-handling gene expression in melanoma cells by dually suppressing the MAPK and PI3K/Akt pathways using specific inhibitors. The gene discussed is PIK3CA; the disease is melanoma.